Northwest & Ethical Investments L.P.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 2033536
TORONTO, A6
Position in REGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$433,451
-$118,436 QoQ
Shares Held
561
-21.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Northwest & Ethical Investments L.P. holds $4,060,177 across 9 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,664 | $3,310,208 | |
| 2 | QURE |
uniQure N.V.
|
2,823 | $130,027 | |
| 3 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,100 | $122,133 | |
| 4 | ZYME |
Zymeworks Inc.
|
4,630 | $121,028 | |
| 5 | MIRM |
Mirum Pharmaceuticals, Inc.
|
896 | $104,894 | |
| 6 | CAI |
Caris Life Sciences, Inc.
|
4,727 | $84,235 | |
| 7 | CGON |
CG Oncology, Inc.
|
1,185 | $84,194 | |
| 8 | ABVX |
Abivax S.A.
|
467 | $62,232 |
All Filings in REGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $433,451 | 561 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $551,887 | 715 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $258,644 | 460 | Shares | Sole | 2025-11-12 | |
| 2023-03-31 | $1,148,694 | 1,398 | Shares | Sole | 2025-07-09 | |
| 2022-12-31 | $1,008,643 | 1,398 | Shares | Sole | 2025-07-09 | |
| 2022-09-30 | $1,534,802 | 2,228 | Shares | Sole | 2025-07-09 | |
| 2022-06-30 | $1,353,096 | 2,289 | Shares | Sole | 2025-07-09 | |
| 2022-03-31 | $1,598,683 | 2,289 | Shares | Sole | 2025-07-09 | |
| 2020-03-31 | $1,361,352 | 2,788 | Shares | Sole | 2025-07-08 | |
| No filing history on record for this holder in this stock. | ||||||